Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-254-0 | CAS number: 3047-32-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29th May 2012 - 8th October 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5300 (Detection of Gene Mutations in Somatic Cells in Culture)
- Deviations:
- not specified
- Principles of method if other than guideline:
- Not applicable.
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 3-ethyloxetane-3-methanol
- EC Number:
- 221-254-0
- EC Name:
- 3-ethyloxetane-3-methanol
- Cas Number:
- 3047-32-3
- Molecular formula:
- C6H12O2
- IUPAC Name:
- (3-ethyloxetan-3-yl)methanol
Constituent 1
- Specific details on test material used for the study:
- Name of test material (as cited in study report): Trimethylolpropane Oxetane
- Physical state: Colourless liquid
- Analytical purity: 99.5%
- Lot/batch No.: 4277708
- Expiration date of the lot/batch: 01 May 2013
- Storage condition of test material: Stored at ambient temperature, protected from light
Method
- Target gene:
- TK locus of mouse lymphoma L5178Y cells
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- The cells used were from the tk+tk- -3.7.2C mouse lymphoma L5178Y cell line. The cells grow in suspension culture, have a generation time of
about 11 h, have a stable, near-diploid chromosome number and have a high cloning efficiency in serum-enriched cloning medium. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Concentrations used in the toxicity test: 0.12, 0.39, 1.16, 3.87, 11.60, 38.72, 116.16, 387.2 and 1161.6 μg/mL
Concentrations used in the four mutation assays (in μg/mL):
Assay 1 (4 hours in the absence of S9 mix): 72.6, 145.2, 290.4, 580.8 and 1161.6
Assay 2 (4 hours exposure in the presence of S9 mix): 72.6, 145.2, 290.4, 580.8 and 1161.6
Assay 3 (24 hours exposure in the absence of S9 mix): 72.6, 145.2, 290.4, 580.8 and 1161.6
Assay 4 (4 hours exposure in the presence of S9 mix): 72.6, 145.2, 290.4, 580.8 and 1161.6 - Vehicle / solvent:
- Water
Controlsopen allclose all
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 250 μg/mL for 4 hour exposure and 100μg/mL for 24 hour exposure
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- In the absence of S9 mix
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 10 μg/mL for 4 hour exposure and 5μg/mL for 24 hour exposure
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- In the absence of S9 mix
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- 2.5 and 10μg/ml for 4 and 24 hour exposure
- Positive control substance:
- 3-methylcholanthrene
- Remarks:
- In the presence of S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
The test item formulations were prepared immediately prior to dosing (within 1 hour). All experimental procedures were conducted using aseptic technique and under amber light.
In the toxicity test, only one culture was prepared for each treatment. The cell population densities were recorded over 2 days (following treatment) using a haemocytometer, then the total suspension growths were expressed as percentages of the vehicle control group (= relative suspension growth, or RSG).
The toxicity test was performed using the standard 4 h exposure period in the absence and presence of S9 mix. An additional toxicity test was performed in the absence of S9 mix with 24 h exposure to Trimethylolpropane Oxetane, as a contingency against the later requirement for a full experiment using this extended exposure period.
Observations on the precipitation of Trimethylolpropane Oxetane were made after dosing and at the end of the exposure period. Observations of pH change (colour change in indicator in RPMI medium) were made and if any change was noted, pH measurements were made.
In the mutation test with 4 hour exposure period, samples of cell culture (in 5 mL R10P) were dispensed to sterile tubes containing R0P (3.9 mL). Freshly prepared S9 mix or R0P (1 mL) was added to each tube followed by the test formulation (0.1 mL). Vehicle control cultures received water (0.1 mL). Positive control cultures received the appropriate solution (0.1 mL). The final reaction mixture in all cultures contained 10 mL of cells, at a population density estimated at 6.0 x 10E5 cells/mL, in R5P medium. All tubes were placed on a 10 r.p.m. rotating drum, inside an incubator set to maintain a temperature of 37°C, for 4 h. After this, the cells were gently sedimented by centrifugation at 200 g for 5 min and resuspended in R10P medium (20 mL). This step was repeated to give a cell density estimated at 3 x 10E5/mL. The cells were returned to the rotating drum and allowed to express their genetic lesions for 2 days. Cell numbers were adjusted, after counting, to an estimated 3 x 10E5 cells/mL on Day 1.
A mutation test with a 24 hour exposure period was conducted when the results of the first experiment in the absence of S9 mix were negative. On the day of the test (Day 0), samples of cell culture (in 10 mL R10P) were dispensed to sterile tubes containing R0P (7.8 mL). R50P (R0P:serum, 50:50, v/v) (2 mL) was added to each tube followed by the test formulation (0.2 mL). Vehicle control cultures received water (0.2 mL). Positive control cultures received the appropriate solution (0.2 mL). The final reaction mixture in all cultures contained 20 mL of cells, at a population density estimated at 3 x 10E5 cells/mL, in R10P medium.
All tubes were incubated on the rotating drum (as described above) for 24 h. After this (on Day 1), the cells were gently sedimented by centrifugation at 200 g for 5 min and were then resuspended in R10P medium (20 mL). This step was repeated. Cell counts were made and the densities adjusted (where higher) to give an estimated 3 x 10E5 cells/mL. The cells were returned to the rotating drum and allowed to express their genetic lesions for 2 days. Cell numbers were adjusted, after counting, to an estimated 3 x 10E5 cells/mL on Day 2.
On Day 2 (4 h exposure) or Day 3 (24 h exposure), cell counts were determined, which provided a measure of suspension growth. the treated cultures from the 4 highest concentrations of Trimethylolpropane Oxetane were selected for final assessment in all 4 assays.
The cultures were then assessed for expression of genetic damage. This was determined by performing parallel cloning assays for cloning efficiency and mutant selection.
For the cloning efficiency assay, each culture was diluted into cloning medium to give an estimated 8 cells/mL. Two 96-well dishes were filled with 200 μL cell culture per well, so giving an estimated 1.6 cells per well.
For the mutant selection assay, TFT stock solution was added to cloning medium to give a final concentration of 3 μg/mL. Into this medium, the cell cultures were diluted to give an estimated 1 x 10E4 cells/mL. Two 96-well dishes were filled with 200 μL cell culture per well, so giving an estimated 2000 cells per well.
All dishes were placed in an incubator set to maintain a humid atmosphere of 5% CO2:95% air (v/v) at 37°C until the colonies were fully developed (at least 9 days for cloning efficiency assay, at least 12 days for mutant selection assay).
The plates were scored using a dissecting microscope fitted to a light box with dark field illumination. The number of empty wells in each plate in the cloning efficiency assay was counted. When scoring the mutant selection assay, separate counts were made of the numbers of wells containing large type and small type colonies.
NUMBER OF REPLICATIONS: Duplicate cultures were tested.
DETERMINATION OF CYTOTOXICITY
- Method: Relative suspension growth and relative total growth, mutant fractions and colony size fractions. - Evaluation criteria:
- Criteria for a Positive Result:
An experiment was considered positive if one or more concentrations showed a biologically significant increase in mutant fraction and there was a significant linear trend. Additional comparisons that can aid interpretation of results include:
a comparison of the induced mutant fraction with the historical maximum for differencebetween vehicle controls
b comparison of the mutant fraction of a treated group with the historical range of vehicle control values
A test item was positive if 2 positive experiments out of 2 were recorded within the same activation condition. Test items that gave a negative response in the standard exposure in the absence of S9 mix, but gave a positive response in the extended exposure, were liable to a confirmatory experiment with the extended exposure.
Criteria for a Negative Result:
A test item was defined as non-mutagenic, provided data were obtained in both the absence and the presence of S9 mix that accompanied one or more of the
following:
• the predetermined maximum concentration of 5000 μg/mL or 10 mM, whichever is lower
• the highest practicable concentration limited by the solubility or pH of the test item
• RTG in the range 10-20% - Statistics:
- The results for each experiment were subjected to a test for linear trend in mutant fraction with concentration of Trimethylolpropane Oxetane by the recommended UKEMS method. Analysis included:
1. Determination of the heterogeneity factor for each dose level.
2. Comparison of the heterogeneity factor with historical control. Any dose levels with heterogeneity factor statistically higher than historical control were excluded from all statistical analysis.
3. Determination of the heterogeneity factor for the experiment.
4. Calculation of a new historical control heterogeneity factor.
5. Calculation of the log mutant fraction.
6. Test for linear increasing trend of mutant fraction with increasing dose of test item (at P<0.05).
All assays were conducted in chronological order. The dose-specific heterogeneity factors were compared with the historical controls for consistency using a one-sided F-test at the 0.1% level. Any dose levels where either the mutant or the survival heterogeneity factors were significantly higher than their respective historical controls were excluded.
The heterogeneity factors were compared with the historical controls for consistency using a one-sided F-test at the 1% level. If either the mutant or the survival heterogeneity factors were significantly higher than their respective historical controls the assay was discarded and the old historical controls remained in place. Otherwise, new historical control heterogeneity factors were calculated, using weighting of 1/20 of the current estimate and 19/20 of the historical estimate.
For each assay not discarded under the above, the following were performed:
The log mutant fraction and its variance were calculated for each dose level,
A one sided χ2 test (Pearson and Hartley (1989)) with 1 degree of freedom was performed at the 5 % level to test for linear increasing trend of mutant fraction with increasing dose of test item, if and only if the direction of the slope parameter was positive.
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity tests:
The results of the toxicity tests show that Trimethylolpropane Oxetane demonstrated minimal toxicity towards the cells. The highest concentration of 1161.6 μg/mL (10 mM) resulted in the following relative suspension growth levels:
In the absence of S9 mix (4 h exposure): 79.0%
In the presence of S9 mix: 58.0%
In the absence of S9 mix (24 h exposure): 45.3%
No precipitation of Trimethylolpropane Oxetane occurred.
Biological relevance was given to any increase in mutant fraction greater than 126 mutants per million above the concurrent control value.
Mutation Assays - 4 hour exposure in the absence and presence of S9 mix:
Trimethylolpropane Oxetane was assessed for mutagenic activity at concentrations of: 145.2, 290.4, 580.8 and 1161.6 μg/mL in the absence (4 h exposure) and presence of S9 mix. In the absence of S9 mix the test for linear trend in mutant fraction with concentration of Trimethylolpropane Oxetane was not reported as the slope was negative. In the presence of S9 mix, the test for linear trend in mutant fraction with concentration of Trimethylolpropane Oxetane was not significant (P=0.80). There was no apparent reduction in relative total growth at the highest concentration of
1161.6 μg/mL (10 mM) in either assay. It was determined that the test substance was considered to be not mutagenic for both assays. As a consequence, the second experiment in the absence of S9 mix was conducted with the extended, 24 h exposure period.
Mutation Assays - 24 hour exposure in the absence and presence of S9 mix:
Trimethylolpropane Oxetane was assessed for mutagenic activity at concentrations of: 145.2, 290.4, 580.8 and 1161.6 μg/mL in the absence (24 h exposure) and presence of S9 mix. The tests for linear trend in mutant fraction with concentration of Trimethylolpropane Oxetane was not significant for either assay (P=0.55 in the absence of S9 mix; P=0.42 in the presence of S9 mix). There was no apparent reduction in relative total growth at the highest concentration of 1161.6 μg/mL (10 mM) in either assay. It was determined that the test substance was considered to be not mutagenic for both assays.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic activation when tested to the predetermined maximum concentration of 1161.6 μg/mL (10 mM).
Under the conditions of this study, Trimethylolpropane Oxetane was not mutagenic in mouse lymphoma L5178Y cells, in either the absence or the presence of S9 mix, when tested to the predetermined maximum concentration of 1161.6 μg/mL (10 mM). - Executive summary:
A study was conducted in accordance with GLP, OECD test guideline 476 and EU Method B.17 to determine the mutagenic potential of Trimethylolpropane Oxetane in a mouse lymphoma L5178Y cell line. Trimethylolpropane Oxetane was formulated in water and tests were conducted both in the absence and in the presence of metabolic activation (S9 mix).
Preliminary cytotoxicity tests showed that Trimethylolpropane Oxetane induced minimal toxicity to the cells at the predetermined maximum concentration of 1161.6 μg/mL (10 mM). Four independent mutation assays were conducted at concentrations of 145.2, 290.4, 580.8 and 1161.6 μg/mL. Positive control cultures were also included (methylmethanesulfonate, ethylmethanesulphonate and 3-methylcholanthrene). Duplicate cultures were carried through the experiments for each treatment point. Vehicle control cultures were also included and were tested in quadruplicate.
Biological relevance was given to any increase in mutant fraction greater than 126 mutants per million above the concurrent control value. In addition, all experiments were tested for dose-related trends in mutant fraction.
No evidence of mutagenic activity was obtained in any experiment. In conclusion, Trimethylolpropane Oxetane was not mutagenic in mouse lymphoma L5178Y cells, in either the absence or the presence of S9 mix, when tested to the predetermined maximum concentration of 1161.6 μg/mL (10 mM).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.